- Report
- February 2026
- 250 Pages
Global
From €4036EUR$4,490USD£3,503GBP
- Report
- January 2026
- 150 Pages
India
From €4359EUR$4,850USD£3,784GBP
- Report
- January 2026
- 150 Pages
Japan
From €4359EUR$4,850USD£3,784GBP
- Report
- October 2025
- 150 Pages
China
From €4359EUR$4,850USD£3,784GBP
- Report
- September 2025
- 150 Pages
Canada
From €4359EUR$4,850USD£3,784GBP
- Report
- March 2025
- 150 Pages
Global
From €4359EUR$4,850USD£3,784GBP
- Report
- June 2023
- 89 Pages
Global
From €3500EUR$4,171USD£3,145GBP
- Report
- November 2025
- 132 Pages
Global
From €854EUR$950USD£741GBP
The Solid Tumor Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and treatment of solid tumors. Solid tumor testing involves the use of various laboratory techniques to detect and identify solid tumors, such as biopsies, imaging, and molecular testing. These tests are used to diagnose and monitor the progression of solid tumors, as well as to determine the best course of treatment. Solid tumor testing is an important part of cancer care, as it helps to identify the type and stage of the tumor, as well as to monitor the effectiveness of treatment.
Some of the major players in the Solid Tumor Testing market include Quest Diagnostics, LabCorp, ARUP Laboratories, Mayo Clinic Laboratories, and NeoGenomics Laboratories. Show Less Read more